Optimal Antithrombotic Treatment of Patients with Atrial Fibrillation Early after an Acute Coronary Syndrome—Triple Therapy, Dual Antithrombotic Therapy with an Anticoagulant… Or, Rather, Temporary Dual Antiplatelet Therapy?

The combination of atrial fibrillation (AF) and acute coronary syndrome (ACS) is a complex situation in which a three-dimensional risk—cardioembolic, coronary, and hemorrhagic—has to be carefully managed. Triple antithrombotic therapy (TAT) is burdened with a high risk of serious bleeding, while dua...

Descripción completa

Detalles Bibliográficos
Autores principales: Limbruno, Ugo, De Sensi, Francesco, Cresti, Alberto, Picchi, Andrea, Lena, Fabio, De Caterina, Raffaele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Viewpoint
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464261/
https://www.ncbi.nlm.nih.gov/pubmed/32824861
http://dx.doi.org/10.3390/jcm9082673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464261/
https://www.ncbi.nlm.nih.gov/pubmed/32824861
http://dx.doi.org/10.3390/jcm9082673

Ejemplares similares